LOS ANGELES: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2023 claims guidelines are not closely followed due to the heterogeneity of symptoms; there is a widespread reluctance to seek treatment in the absence of curative therapies; diagnosis in early stages of the disease remains a challenge and will affect the growth of the market over the 2013-2023 forecast period and poor consensus over clinical trial endpoints are required for approval.